
Brand Name | Status | Last Update |
|---|---|---|
| fucidin | unapproved drug other | 2019-10-07 |

Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Impetigo | D007169 | EFO_1000714 | L01 | — | — | 1 | — | 1 | 2 |
| Bacterial infections | D001424 | — | A49 | — | — | 1 | — | — | 1 |
| Infectious skin diseases | D012874 | — | — | — | — | 1 | — | — | 1 |
| Bacterial skin diseases | D017192 | — | — | — | — | 1 | — | — | 1 |
| Cellulitis | D002481 | EFO_0003035 | L03.90 | — | — | 1 | — | — | 1 |
| Drug common name | Fusidic acid |
| INN | fusidic acid |
| Description | Fusidic acid is a steroid antibiotic that is isolated from the fermentation broth of Fusidium coccineum. It has a role as a protein synthesis inhibitor, an EC 2.7.1.33 (pantothenate kinase) inhibitor and an Escherichia coli metabolite. It is a 3alpha-hydroxy steroid, an 11alpha-hydroxy steroid, a sterol ester, a steroid acid, an alpha,beta-unsaturated monocarboxylic acid and a steroid antibiotic. It is a conjugate acid of a fusidate. It derives from a hydride of a 5alpha-cholestane. |
| Classification | Small molecule |
| Drug class | — |
| Image (chem structure or protein) | ![]() |
| Structure (InChI/SMILES or Protein Sequence) | CC(=O)O[C@H]1C[C@@]2(C)[C@@H](C[C@@H](O)[C@H]3[C@@]4(C)CC[C@@H](O)[C@@H](C)[C@@H]4CC[C@@]32C)/C1=C(\CCC=C(C)C)C(=O)O |
| PDB | — |
| CAS-ID | 6990-06-3 |
| RxCUI | — |
| ChEMBL ID | CHEMBL374975 |
| ChEBI ID | 29013 |
| PubChem CID | 3000226 |
| DrugBank | DB02703 |
| UNII ID | 59XE10C19C (ChemIDplus, GSRS) |

